|
1
|
Finlay IG and McArdle CS: Effect of occult
hepatic metastases on survival after curative resection for
colorectal carcinoma. Gastroenterology. 85:596–599. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kemp Z, Thirlwell C, Sieber O, Silver A
and Tomlinson I: An update on the genetics of colorectal cancer.
Hum Mol Genet. 13(Spec No 2): R177–185. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Konishi M, Kikuchi-Yanoshita R, Tanaka K,
Muraoka M, Onda A, Okumura Y, Kishi N, Iwama T, Mori T, Koike M, et
al: Molecular nature of colon tumors in hereditary nonpolyposis
colon cancer, familial polyposis, and sporadic colon cancer.
Gastroenterology. 111:307–317. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Erning FN, Crolla RM, Rutten HJ,
Beerepoot LV, van Krieken JH and Lemmens VE: No change in lymph
node positivity rate despite increased lymph node yield and
improved survival in colon cancer. Eur J Cancer. 50:3221–3229.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang F, Luo Y, Shao Z, Xu L, Liu X, Niu
Y, Shi J, Sun X, Liu Y, Ding Y and Zhao L: MicroRNA-187, a
downstream effector of TGFβ pathway, suppresses Smad-mediated
epithelial-mesen-chymal transition in colorectal cancer. Cancer
Lett. 373:203–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang P, Tang WM, Zhang H, Li YQ, Peng Y,
Wang J, Liu GN, Huang XT, Zhao JJ, Li G, et al: MiR-646 inhibited
cell proliferation and EMT-induced metastasis by targeting FOXK1 in
gastric cancer. Br J Cancer. 117:525–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu X, Li J, Yu Z, Li J, Sun R and Kan Q:
miR-935 promotes liver cancer cell proliferation and migration by
targeting SOX7. Onco Res. 25:427–435. 2017. View Article : Google Scholar
|
|
8
|
Guo Y, Chen L, Sun C and Yu C:
MicroRNA-500a promotes migration and invasion in hepatocellular
carcinoma by activating the Wnt/β-catenin signaling pathway. Biomed
Pharmacother. 91:13–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ruiz-Lafuente N, Alcaraz-Garcia MJ,
Sebastian-Ruiz S, Garcia-Serna AM, Gomez-Espuch J, Moraleda JM,
Minguela A, Garcia-Alonso AM and Parrado A: IL-4 Up-regulates
MiR-21 and the MiRNAs hosted in the CLCN5 gene in chronic
lymphocytic leukemia. PLoS One. 10:e01249362015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Degli Esposti D, Aushev VN, Lee E, Cros
MP, Zhu J, Herceg Z, Chen J and Hernandez-Vargas H: miR-500a-5p
regulates oxidative stress response genes in breast cancer and
predicts cancer survival. Sci Rep. 7:159662017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang M, Zhou LY, Xu N and An Q:
Down-regulation of miR-500 and miR-628 suppress non-small cell lung
cancer proliferation, migration and invasion by targeting ING1.
Biomed Pharmacother. 108:1628–1639. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang W, Zhou W, Xiang L, Wu X, Zhang P,
Wang J, Liu G, Zhang W, Peng Y, Huang X, et al: The
p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell
proliferation in human colorectal cancer. Nat Commun. 10:6632019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang MH, Wu MZ, Chiou SH, Chen PM, Chang
SY, Liu CJ, Teng SC and Wu KJ: Direct regulation of TWIST by
HIF-1alpha promotes metastasis. Nat Cell Biol. 10:295–305. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang W, Jiang B, Guo Z, Sardet C, Zou B,
Lam CS, Li J, He M, Lan HY, Pang R, et al: Four-and-a-half LIM
protein 2 promotes invasive potential and epithelial-mesenchymal
transition in colon cancer. Carcinogenesis. 31:1220–1229. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan Q, Zhang W, Wu Y, Wu M, Zhang M, Shi
X, Zhao J, Nan Q, Chen Y, Wang L, et al: KLF8 promotes
tumorigenesis, invasion and metastasis of colorectal cancer cells
by transcriptional activation of FHL2. Oncotarget. 6:25402–25417.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang X, Xiang L, Li Y, Zhao Y, Zhu H,
Xiao Y, Liu M, Wu X, Wang Z, Jiang P, et al: Snail/FOXK1/Cyr61
signaling axis regulates the epithelial-mesenchymal transition and
metastasis in colorectal cancer. Cell Physiol Biochem. 47:590–603.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nature reviews Mol
Cell Biol. 15:178–196. 2014. View Article : Google Scholar
|
|
18
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: TGF-β-induced upregulation of malat1 promotes bladder
cancer metastasis by associating with suz12. Clin Cancer Res.
20:1531–1541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu H, Wang H, Liu X and Yu T: miR-1271
inhibits migration, invasion and epithelial-mesenchymal transition
by targeting ZEB1 and TWIST1 in pancreatic cancer cells. Biochem
Biophys Res Commun. 472:346–352. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Demirezer LO, Kuruuzum-Uz A, Bergere I,
Schiewe HJ and Zeeck A: The structures of antioxidant and cytotoxic
agents from natural source: Anthraquinones and tannins from roots
of Rumex patientia. Phytochemistry. 58:1213–1217. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang Q, Lu G, Shen HM, Chung MC and Ong
CN: Anti-cancer properties of anthraquinones from rhubarb. Med Res
Rev. 27:609–630. 2007. View Article : Google Scholar
|
|
22
|
Li J, Liu P, Mao H, Wanga A and Zhang X:
Emodin sensitizes paclitaxel-resistant human ovarian cancer cells
to paclitaxel-induced apoptosis in vitro. Oncol Rep. 21:1605–1610.
2009.PubMed/NCBI
|
|
23
|
Dong X, Fu J, Yin X, Cao S, Li X, Lin L,
Huyiligeqi and Ni J: Emodin: A review of its pharmacology, toxicity
and pharmaco-kinetics. Phytother Res. 30:1207–1218. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ko JC, Su YJ, Lin ST, Jhan JY, Ciou SC,
Cheng CM and Lin YW: Suppression of ERCC1 and Rad51 expression
through ERK1/2 inactivation is essential in emodin-mediated
cytotoxicity in human non-small cell lung cancer cells. Biochem
Pharmacol. 79:655–664. 2010. View Article : Google Scholar
|
|
25
|
He Y, Huang J, Wang P, Shen X, Li S, Yang
L, Liu W, Suksamrarn A, Zhang G and Wang F: Emodin potentiates the
antiproliferative effect of interferon α/β by activation of
JAK/STAT pathway signaling through inhibition of the 26S
proteasome. Oncotarget. 7:4664–4679. 2016.
|
|
26
|
Cai J, Niu X, Chen Y, Hu Q, Shi G, Wu H,
Wang J and Yi J: Emodin-induced generation of reactive oxygen
species inhibits RhoA activation to sensitize gastric carcinoma
cells to anoikis. Neoplasia. 10:41–51. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Gorkom BA, Timmer-Bosscha H, de Jong
S, van der Kolk DM, Kleibeuker JH and de Vries EG: Cytotoxicity of
rhein, the active metabolite of sennoside laxatives, is reduced by
multidrug resistance-associated protein 1. Br J Cancer.
86:1494–1500. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Niu Y, Zhang J, Tong Y, Li J and Liu B:
Physcion 8-O-β-glucopyranoside induced ferroptosis via regulating
miR-103a-3p/GLS2 axis in gastric cancer. Life Sci. 237:1168932019.
View Article : Google Scholar
|
|
29
|
Li N, Wang C, Zhang P and You S: Emodin
inhibits pancreatic cancer EMT and invasion by upregulating
microRNA1271. Mol Med Rep. 18:3366–3374. 2018.PubMed/NCBI
|
|
30
|
Wang J, Yang Y, Xia HH, Gu Q, Lin MC,
Jiang B, Peng Y, Li G, An X, Zhang Y, et al: Suppression of FHL2
expression induces cell differentiation and inhibits gastric and
colon carcinogenesis. Gastroenterology. 132:1066–1076. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
32
|
Liu B, Li X, Li C, Xu R and Sun X: miR-25
mediates metastasis and epithelial-mesenchymal-transition in human
esophageal squamous cell carcinoma via regulation of E-cadherin
signaling. Bioengineered. 10:679–688. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li S, Hou X, Wu C, Han L, Li Q, Wang J and
Luo S: MiR-645 promotes invasiveness, metastasis and tumor growth
in colorectal cancer by targeting EFNA5. Biomed Pharmacother.
125:1098892020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang HC, Hu CH, Tang MC, Wang WS, Chen PM
and Su Y: Thymosin beta4 triggers an epithelial-mesenchymal
transition in colorectal carcinoma by upregulating integrin-linked
kinase. Oncogene. 26:2781–2790. 2007. View Article : Google Scholar
|
|
35
|
Schelch K, Wagner C, Hager S, Pirker C,
Siess K, Lang E, Lin R, Kirschner MB, Mohr T, Brcic L, et al: FGF2
and EGF induce epithelial-mesenchymal transition in malignant
pleural mesothelioma cells via a MAPKinase/MMP1 signal.
Carcinogenesis. 39:534–545. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen L, Sun DZ, Fu YG, Yang PZ, Lv HQ, Gao
Y and Zhang XY: Upregulation of microRNA-141 suppresses
epithelial-mesenchymal transition and lymph node metastasis in
laryngeal cancer through HOXC6-dependent TGF-β signaling pathway.
Cell Signal. 66:1094442020. View Article : Google Scholar
|
|
37
|
Gu J, Cui CF, Yang L, Wang L and Jiang XH:
Emodin inhibits colon cancer cell invasion and migration by
suppressing epithelial-mesenchymal transition via the Wnt/β-catenin
pathway. Oncol Res. 27:193–202. 2019. View Article : Google Scholar
|
|
38
|
Larsson O, Li S, Issaenko OA, Avdulov S,
Peterson M, Smith K, Bitterman PB and Polunovsky VA: Eukaryotic
translation initiation factor 4E induced progression of primary
human mammary epithelial cells along the cancer pathway is
associated with targeted translational deregulation of oncogenic
drivers and inhibitors. Cancer Res. 67:6814–6824. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu J, Xie F, Bao X, Chen W and Xu Q:
miR-300 inhibits epithelial to mesenchymal transition and
metastasis by targeting Twist in human epithelial cancer. Mol
Cancer. 13:1212014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh
T, Kojima K, Nakashima R, Kitade Y and Naoe T: Role of
anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer
Gene Ther. 17:398–408. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu F, Cai Y, Rong X, Chen J, Zheng D,
Chen L, Zhang J, Luo R, Zhao P and Ruan J: MiR-661 promotes tumor
invasion and metastasis by directly inhibiting RB1 in non small
cell lung cancer. Mol Cancer. 16:1222017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang C, Xie D, Cui J, Li Q, Gao Y and Xie
K: FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal
transition and metastasis via upregulation of expression of the
urokinase plas-minogen activator system. Clin Cancer Res.
20:1477–1488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qi H, Fu X, Li Y, Pang X, Chen S, Zhu X,
Li F and Tan W: SATB1 promotes epithelial-mesenchymal transition
and metastasis in prostate cancer. Oncol Lett. 13:2577–2582. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sun S, Hang T, Zhang B, Zhu L, Wu Y, Lv X,
Huang Q and Yao H: miRNA-708 functions as a tumor suppressor in
colorectal cancer by targeting ZEB1 through Akt/mTOR signaling
pathway. Am J Transl Res. 11:5338–5356. 2019.PubMed/NCBI
|
|
45
|
Guan T, Dominguez CX, Amezquita RA,
Laidlaw BJ, Cheng J, Henao-Mejia J, Williams A, Flavell RA, Lu J
and Kaech SM: ZEB1, ZEB2, and the miR-200 family form a
counterregulatory network to regulate CD8+ T cell fates.
J Exp Med. 215:1153–1168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sousa-Squiavinato ACM, Rocha MR,
Barcellos-de-Souza P, de Souza WF and Morgado-Diaz JA: Cofilin-1
signaling mediates epithelial-mesenchymal transition by promoting
actin cytoskeleton reorganization and cell-cell adhesion regulation
in colorectal cancer cells. Biochim Biophys Acta Mol Cell Res.
1866:418–429. 2019. View Article : Google Scholar
|
|
47
|
Islam SU, Ahmed MB, Lee SJ, Shehzad A,
Sonn JK, Kwon OS and Lee YS: PRP4 kinase induces actin
rearrangement and epithelial-mesenchymal transition through
modulation of the actin-binding protein cofilin. Exp Cell Res.
369:158–165. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu F, Chen N, Xiao R, Wang W and Pan Z:
miR-144-3p serves as a tumor suppressor for renal cell carcinoma
and inhibits its invasion and metastasis by targeting MAP3K8.
Biochem Biophys Res Commun. 480:87–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jurmeister S, Baumann M, Balwierz A,
Keklikoglou I, Ward A, Uhlmann S, Zhang JD, Wiemann S and Sahin O:
MicroRNA-200c represses migration and invasion of breast cancer
cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Mol
Cell Biol. 32:633–651. 2012. View Article : Google Scholar :
|
|
50
|
Shen W, Tao GQ, Zhang Y, Cai B, Sun J and
Tian ZQ: TGF-β in pancreatic cancer initiation and progression: Two
sides of the same coin. Cell Biosci. 7:392017. View Article : Google Scholar
|
|
51
|
Zhou Q, Zheng X, Chen L, Xu B, Yang X,
Jiang J and Wu C: Smad2/3/4 pathway contributes to TGF-β-Induced
MiRNA-181b expression to promote gastric cancer metastasis by
targeting Timp3. Cell Physiol Biochem. 39:453–466. 2016. View Article : Google Scholar
|
|
52
|
Chen WX, Zhang ZG, Ding ZY, Liang HF, Song
J, Tan XL, Wu JJ, Li GZ, Zeng Z, Zhang BX and Chen XP: MicroRNA-630
suppresses tumor metastasis through the TGF-beta- miR-630-Slug
signaling pathway and correlates inversely with poor prognosis in
hepatocellular carcinoma. Oncotarget. 7:22674–22686.
2016.PubMed/NCBI
|
|
53
|
Chun-Guang W, Jun-Qing Y, Bei-Zhong L,
Dan-Ting J, Chong W, Liang Z, Dan Z and Yan W: Anti-tumor activity
of emodin against human chronic myelocytic leukemia K562 cell lines
in vitro and in vivo. Eur J Pharmacol. 627:33–41. 2010. View Article : Google Scholar
|
|
54
|
Han YT, Chen XH, Gao H, Ye JL and Wang CB:
Physcion inhibits the metastatic potential of human colorectal
cancer SW620 cells in vitro by suppressing the transcription factor
SOX2. Acta Pharmacol Sin. 37:264–275. 2016. View Article : Google Scholar :
|
